Hangzhou LinkZill Technology Co., Ltd. has recently completed a multi-million-dollar A-round financing, exclusively led by Proxima Ventures. The funds will be used to accelerate product delivery and global market expansion.
Company Background
Founded in 2019 with its headquarters in Hangzhou, China, and a research and business center in Cambridge, UK, LinkZill has been dedicated to advancing TFT (Thin-Film Transistor) semiconductor technology across life sciences, novel sensing, and display applications. In 2023, the company established a TFT semiconductor R & D center in Hangzhou, focusing on global cross-industrial development of TFT semiconductor technology. To date, LinkZill has served over 300 clients worldwide, with operations spanning more than 20 countries and regions.
Product Innovations
LinkZill’s first product for life sciences is based on its “flexible throughput and flexible loading DNA synthesis technology” using TFT semiconductors. The company launched the world’s first desktop TFT-DNA synthesizer, a terminal device that employs TFT chip-based DNA synthesis. This innovation not only opens up new technological pathways but also mitigates risks associated with semiconductor trade barriers by leveraging China’s TFT semiconductor supply chain advantages, enabling cost-effective, large-scale production of life science devices.
Commercialization and Future Plans
LinkZill has achieved full commercialization across its product portfolio, including terminal devices, chip consumables, and synthetic products. The company has successfully delivered angel customer projects for three product forms: oligonucleotide microarrays, oligonucleotide pools, and genes. Its first standardized product, the TruArray™ Std 4K high-throughput oligonucleotide microarray, is now available. In parallel, LinkZill is rapidly advancing the development of additional products, including the TruPool™ 4K-plex oligonucleotide pool and high-density oligonucleotide microarrays with capacities ranging from 65K to 1M. These are expected to launch by year-end. The company is also expanding its life science product applications, tools, and comprehensive solutions, targeting areas such as spatial transcriptomics, rapid detection of pathogenic microbes, and AI-assisted protein design. LinkZill aims to become a trusted partner for clients in the era of AI-driven scientific innovation.-Fineline Info & Tech
Leave a Reply